About Replimune Group Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.replimune.com/
Frequently Asked Questions
What is the 52-week range for REPL?
The 52-week high is $16.33 and the 52-week low is $1.5.
What is the P/E ratio for REPL?
The P/E ratio data is currently unavailable.
What is the dividend yield for REPL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -159.32%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.80.
Analyst Recommendation Trends
Wall Street analyst consensus for REPL over the last few months:
Latest REPL News
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
ReplimuneConnect Plus a comprehensive program that provides dedicated support and resources to help eligible patients access TUDRIQEV in the U.S. now liveWOBURN, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that TUDRIQEV™ (vusolimogene oderparepvec-wtpg) is now commercially available in the United States. TUDRIQEV is indicated in combination wi
Replimune Group Announces Commercial Availability Of TUDRIQEV In U.S. To Treat Unresectable Advanced Cutaneous Melanoma
Replimune Group, Inc. (NASDAQ:REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that TUDRIQEV™ (vusolimogene oderparepvec-wtpg) is now
Replimune Says Stockholders Approved Amendment To Increase Authorized Common Shares From 150M To 300M, Effective September 15
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001737953/000110465926108243/tm2625488d1_8k.htm
Replimune Group, Inc. (REPL) Shareholder/Analyst Call Prepared Remarks Transcript
Replimune Group, Inc. (REPL) Shareholder/Analyst Call September 15, 2026 8:30 AM EDTCompany ParticipantsPhilip Astley-Sparke - Executive ChairmanShawn...
HQL: The Rally That Makes Growth Harder (Rating Downgrade)
HQL downgraded to Hold after big rally; 12.5% yield, NAV discount and payout risks weigh on upside.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-20 | Astley-Sparke Philip | -50,000 | - | - |
| 2026-08-17 | Hill Emily Luisa | -9,256 | $14.28 | $132,176 |
| 2026-08-11 | BAKER BROS. ADVISORS LP | +2,609,946 | $12.0599 | $31,475,688 |
| 2026-08-11 | BAKER BROS. ADVISORS LP | +126,394 | $12.0599 | $1,524,299 |
| 2026-08-10 | Patel Sushil | -39,341 | $12.97 | $510,253 |
| 2026-08-10 | Hill Emily Luisa | -11,448 | $12.97 | $148,481 |
| 2026-08-10 | Xynos Konstantinos | -11,447 | $12.97 | $148,468 |
| 2026-08-10 | Schwendenman Andrew | -7,632 | $12.97 | $98,987 |
| 2026-06-01 | Sarchi Christopher | -12,000 | $9.24 | $110,880 |
| 2026-05-18 | Xynos Konstantinos | -14,023 | $5.08 | $71,237 |
| 2026-05-18 | Schwendenman Andrew | -7,894 | $5.08 | $40,102 |
| 2026-05-18 | Sarchi Christopher | -8,626 | $5.08 | $43,820 |
| 2026-05-18 | Patel Sushil | -37,324 | $5.08 | $189,606 |
| 2026-05-18 | Hill Emily Luisa | -7,812 | $5.08 | $39,685 |
| 2026-05-18 | Astley-Sparke Philip | -17,657 | $5.08 | $89,698 |
| 2026-04-02 | Sarchi Christopher | -6,500 | $8.01 | $52,065 |
| 2026-04-01 | Sarchi Christopher | +75,000 | - | - |
| 2026-04-01 | Sarchi Christopher | +50,000 | - | - |
| 2026-04-01 | Oliger Christy J. | +44,500 | - | - |
| 2026-04-01 | Xynos Konstantinos | +75,000 | - | - |
| 2026-04-01 | Xynos Konstantinos | +50,000 | - | - |
| 2026-04-01 | Schwendenman Andrew | +55,000 | - | - |
| 2026-04-01 | Schwendenman Andrew | -36,667 | - | - |
| 2026-04-01 | Patel Sushil | +376,860 | - | - |
| 2026-04-01 | Patel Sushil | +251,240 | - | - |
| 2026-04-01 | Peeples-Dyer Veleka | +44,500 | - | - |
| 2026-04-01 | Hill Emily Luisa | +75,000 | - | - |
| 2026-04-01 | Hill Emily Luisa | +50,000 | - | - |
| 2026-04-01 | Weinand Dieter | +44,500 | - | - |
| 2026-04-01 | Balachandran Madhavan | +44,500 | - | - |
| 2026-04-01 | Dhingra Kapil | +44,500 | - | - |
| 2026-04-01 | Pucci Paolo | +44,500 | - | - |
| 2026-04-01 | Astley-Sparke Philip | +75,000 | - | - |
| 2026-04-01 | Astley-Sparke Philip | +50,000 | - | - |
| 2026-04-01 | SLATTERY JOSEPH P | +44,500 | - | - |
| 2026-04-01 | BAKER JULIAN | +44,500 | - | - |
| 2026-04-01 | BAKER JULIAN | +44,500 | - | - |
| 2026-02-18 | Astley-Sparke Philip | -25,000 | - | - |
| 2025-12-19 | Patel Sushil | +200,000 | - | - |
| 2025-12-19 | Xynos Konstantinos | +60,000 | - | - |
| 2025-12-19 | Hill Emily Luisa | +60,000 | - | - |
| 2025-12-19 | Sarchi Christopher | +35,000 | - | - |
| 2025-12-19 | Schwendenman Andrew | +10,000 | - | - |
| 2025-12-09 | Dhingra Kapil | -3,169 | - | - |
| 2025-12-09 | Dhingra Kapil | -3,169 | $10.4 | $32,958 |
| 2025-12-09 | Dhingra Kapil | +3,169 | $1.75 | $5,546 |
| 2025-12-02 | Patel Sushil | -10,000 | $11.13 | $111,300 |
| 2025-11-17 | Sarchi Christopher | -5,208 | $9.1 | $47,393 |
| 2025-11-17 | Xynos Konstantinos | -7,248 | $9.1 | $65,957 |